Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Herran
Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation
Jounal of arrhythmology
Practical Guide to Choosing Dabigatran 150 Mg Twice Daily or Apixaban 5 Mg Twice Daily for Patients With Atrial Fibrillation
Journal of Rural Medicine
How to Use Dabigatran in Patients With Atrial Fibrillation
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data
Journal of managed care & specialty pharmacy
Health Policy
Pharmacy
Pharmaceutical Science
Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
